Semi-Annual Consolidated Statement Of Comprehensive Income

Daito Pharmaceutical Co., Ltd. - Filing #7727185

Concept 2017-06-01 to
2018-02-28
2016-06-01 to
2017-02-28
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
2,280,208,000 JPY
2,022,323,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
156,266,000 JPY
-144,843,000 JPY
Foreign currency translation adjustment
90,938,000 JPY
-52,783,000 JPY
Remeasurements of defined benefit plans, net of tax
3,186,000 JPY
130,982,000 JPY
Other comprehensive income
250,391,000 JPY
-66,644,000 JPY
Comprehensive income
2,530,599,000 JPY
1,955,679,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,523,019,000 JPY
1,993,016,000 JPY
Comprehensive income attributable to non-controlling interests
7,580,000 JPY
-37,337,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.